Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: RETRACTED ARTICLE: Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease

Fig. 1

a Schematic interpretation of T807/RPCNP-CUR in vivo. According to the precise targeting of T807, the novel biomimetic engineered delivery nanosystems accumulate in neurons after crossing the BBB. b The preparation of T807/RPCNP-CUR. First, the RBCm was derived from RBCs and bare NPs were prepared using an emulsification ultrasonication method. Next, the resulting RBC membranes were coated onto the surface of bare NPs through mechanical extrusion to form RPCNP-CUR. Finally, DSPE-PEG3400-T807 was inserted into the outer monolayer of RBCm to form T807/RPCNP-CUR NPs

Back to article page